Table 1
The number of patients according to the number and type of dentures they received in prosthodontic treatment in the Primary Health Centres of the three regions of Kosovo from 2002 to 2013.
| CD | ARPD | Total | |
|---|---|---|---|
| 4,483 | 8,966 | 8,966 | |
| 1,647 | 1,647 | 1,647 | |
| 1,042 | 1,042 | 1,042 | 2,084 |
| 1,053 | 2,086 | 2,106 | |
| 1,253 | 1,253 | 1,253 | |
| Ʃ9,478 | Ʃ11,655 | Ʃ4,401 | Ʃ16,056 |
Table 2
Population size in the three regions of Kosovo registered in 2011.
| Age group | Prizren | Peje/Peč | Ferizaj/ Uroševac | Total |
|---|---|---|---|---|
| <35 | 111,468 | 57,811 | 69,212 | 238,491 |
| 35–44 | 24,767 | 13,150 | 14,750 | 52,667 |
| 45–54 | 18,452 | 10,658 | 10,822 | 39,932 |
| 55–64 | 11,690 | 7,337 | 7,269 | 26,296 |
| 65–74 | 7,443 | 4,917 | 4,570 | 16,930 |
| 75+ | 3,961 | 2,577 | 1,987 | 8,525 |
| Total | 177,781 | 96,450 | 108,610 | 382,841 |
Figure 1
The number of new treatments with CDs and ARPDs for each year of denture delivery in the Primary Health Centres of Kosovo.
Figure 2
The linear trend of CD and ARPD delivery in three regions of Kosovo from 2002 to 2013.
Table 3
Binominal logistic regression model predicting odds of ARPD versus CD treatment by year of receiving the treatment (2002–2013) and patient characteristics.
| Observed category | Reference category | AOR (95% CI) ARPD to CD | p |
|---|---|---|---|
| Year of delivery | |||
| 2013 | 2002 | 1.042 (1.030–1.054) | 0.001* |
| Sex | |||
| [Male] | [Female] | 1.291 (1.197–1.392) | 0.001* |
| Age | |||
| [<34 years] | [75+ years] | 13.935 (10.296–18.861) | 0.001* |
| [35–44 years] | [75+ years] | 6.201 (5.181–7.422) | 0.001* |
| [45–54 years] | [75+ years] | 3.541 (3.031–4.137) | 0.001* |
| [55–64 years] | [75+ years] | 2.519 (2.163–2.934) | 0.001* |
| [65–74 years] | [75+ years] | 1.512 (1.299–1.759) | 0.001* |
| Residence | |||
| [Rural] | [Urban] | 1.102 (1.008–1.205) | 0.033* |
| Jaws | |||
| [Mandibula] | [Maksila] | 2.996 (2.778–3.231) | 0.001* |
[i] *marks statistically significant differences (p<0.05)
Figure 3
The distribution of the proportion of population treated with CDs and ARPDs from 2010 to 2013, at an annual level, by the age groups >35, 35–44, 45–54, 55–64, 75+, 35+ and in total.